Web Analytics

3 Latest Announced Rounds

  • $67,000,000
    Series A
    Biotechnology Research
    Apr 2nd, 2025
  • $10,000,000
    Seed

    2 Investors

    Software Development
    Apr 2nd, 2025
  • $5,200,000
    Series A

    3 Investors

    Technology, Information and Internet
    Apr 2nd, 2025
$1,676.17M Raised in 53 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Angitia Biopharmaceuticals

start up
United States - Woodland Hills, CA
  • 12/12/2024
  • Series C
  • $120,000,000

Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need.


Related People

Hua Zhu (David) KeFounder

Hua Zhu (David) Ke United States - Greater Los Angeles, California

Discovery and translational research professional, specifically in bone and renal diseases.